Ms
Hailey
Hornsby
School of Medicine and Population Health
Postdoctoral Research Associate
HAILEY.HORNSBY@SHEFFIELD.AC.UK
+44 114 215 9579
+44 114 215 9579
Room LU112, L Floor, Royal Hallamshire Hospital
Full contact details
Ms Hailey Hornsby
Room LU112, L Floor
Royal Hallamshire Hospital
School of Medicine and Population Health
Room LU112, L Floor
Royal Hallamshire Hospital
Glossop Road
Sheffield
S10 2JF
- Publications
-
Journal articles
- Dynamic impact of bivalent COVID-19 vaccine boosters on systemic and mucosal antibody and T cell immunity. Scientific Reports, 15. View this article in WRRO
- Compartmentalised mucosal and blood immunity to SARS-CoV-2 is associated with high seroprevalence before the Delta wave in Africa. Communications Medicine, 5(1). View this article in WRRO
- Greater preservation of SARS‐CoV‐2 neutralising antibody responses following the ChAdOx1‐S (AZD1222) vaccine compared with mRNA vaccines in haematopoietic cell transplant recipients. British Journal of Haematology, 205(6), 2206-2218. View this article in WRRO
- Efficient overexpression and purification of severe acute respiratory syndrome coronavirus 2 nucleocapsid proteins in Escherichia coli. Biochemical Journal, 481(11), 669-682. View this article in WRRO
- High SARS-CoV-2 incidence and asymptomatic fraction during Delta and Omicron BA.1 waves in The Gambia. Nature Communications, 15(1). View this article in WRRO
- Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection history. Nature Communications, 14(1). View this article in WRRO
- Establishing SARS-CoV-2 membrane protein-specific antibodies as a valuable serological target via high-content microscopy. iScience, 26(7). View this article in WRRO
- Streptococcus pyogenes Colonization in Children Aged 24–59 Months in the Gambia: Impact of Live Attenuated Influenza Vaccine and Associated Serological Responses. The Journal of Infectious Diseases, 228(7), 957-965. View this article in WRRO
- Rapid escape of new SARS-CoV-2 Omicron variants from BA.2-directed antibody responses. Cell Reports, 42(4). View this article in WRRO
- Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens. Med, 4(3), 191-215.e9. View this article in WRRO
- A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75. Cell Reports, 42(1). View this article in WRRO
- mRNA vaccination drives differential mucosal neutralizing antibody profiles in naïve and SARS-CoV-2 previously-infected individuals. Frontiers in Immunology, 13. View this article in WRRO
- Recurrent SARS-CoV-2 mutations in immunodeficient patients. Virus Evolution, 8(2). View this article in WRRO
- Altered subgenomic RNA abundance provides unique insight into SARS-CoV-2 B.1.1.7/Alpha variant infections. Communications Biology, 5. View this article in WRRO
- Risk factors for SARS-CoV-2 seroprevalence following the first pandemic wave in UK healthcare workers in a large NHS Foundation Trust [version 2; peer review: 1 approved]. Wellcome Open Research, 6. View this article in WRRO
- The impact of viral mutations on recognition by SARS-CoV-2 specific T cells. iScience, 24(11). View this article in WRRO
- Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine. Cell, 184(23), 5699-5714.e11. View this article in WRRO
- Risk factors for SARS-CoV-2 seroprevalence following the first pandemic wave in UK healthcare workers in a large NHS Foundation Trust. Wellcome Open Research, 6. View this article in WRRO
- D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization. Cell Host & Microbe, 29(1), 23-31.e4. View this article in WRRO
- The SARS-CoV-2 Alpha variant was associated with increased clinical severity of COVID-19 in Scotland: A genomics-based retrospective cohort analysis. PLOS ONE, 18(4), e0284187-e0284187.
- Publisher Correction: SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway. Nature Microbiology, 7(10), 1709-1709.
Preprints
- Dynamic impact of bivalent COVID-19 vaccine boosters on systemic and mucosal immunity– an observational cohort study, Springer Science and Business Media LLC.
- Compartmentalised mucosal and blood immunity to SARS-CoV-2 associated with high seroprevalence before Delta wave in Africa, Springer Science and Business Media LLC.
- Efficient overexpression and purification of SARS-CoV-2 Nucleocapsid proteins in
Escherichia coli, openRxiv.
- Omicron BA.1/BA.2 infections in triple-vaccinated individuals enhance a diverse repertoire of mucosal and blood immune responses, openRxiv.
- Streptococcus pyogenes
colonization in children aged 24-59 months in The Gambia: Impact of Live Attenuated Influenza Vaccine and associated serological responses, openRxiv.
- Evolution of long-term vaccine induced and hybrid immunity in healthcare workers after different COVID-19 vaccination regimens: a longitudinal observational cohort study, openRxiv.
- A high content microscopy-based platform for detecting antibodies to the nucleocapsid, spike and membrane proteins of SARS-CoV-2, openRxiv.
- Altered Subgenomic RNA Expression in SARS-CoV-2 B.1.1.7 Infections, openRxiv.
- T-Cell and Antibody Responses to First BNT162b2 Vaccine Dose in Previously SARS-CoV-2-Infected and Infection-Naive UK Healthcare Workers: A Multicentre, Prospective, Observational Cohort Study, Elsevier BV.
- D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization, openRxiv.
- Evolution of Long-Term Hybrid Immunity in Healthcare Workers after Different Covid-19 Vaccination Regimens: A Longitudinal Observational Cohort Study.
- Risk factors for SARS-CoV-2 seroprevalence following the first pandemic wave in UK healthcare workers in a large NHS Foundation Trust. View this article in WRRO
- Dynamic impact of bivalent COVID-19 vaccine boosters on systemic and mucosal antibody and T cell immunity. Scientific Reports, 15. View this article in WRRO